Search research articles
Contact Us
Filters
Showing results (291-300 of 328) with videos related to
Page
of 33
Sort By:
The British Journal of Dermatology
|
April 15, 2014
Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma
E Guenova, S Schanz, W Hoetzenecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
U Keilholz, S H Goey, C J Punt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 20, 2024
Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis
M Brandlmaier, M Hoellwerth, T Silly, et al.
British Journal of Cancer
|
April 20, 2001
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
A Hauschild, C Garbe, W Stolz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 29, 2015
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study
M Kunz, M Urosevic-Maiwald, S M Goldinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Frontiers in Oncology
|
December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
H S Gabryś, L Basler, S Burgermeister, et al.
Nature Medicine
|
October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial
R Dummer, D E Gyorki, J Hyngstrom, et al.
The British Journal of Dermatology
|
September 2, 2018
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial
E Stockfleth, G F L Hofbauer, U Reinhold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2011
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
R von Moos, B Seifert, M Simcock, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 328) with videos related to
Sort By:
Page
of 33
The British Journal of Dermatology
|
April 15, 2014
Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma
E Guenova, S Schanz, W Hoetzenecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Interferon alfa-2a and interleukin-2 with or without cisplatin in metastatic melanoma: a randomized trial of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
U Keilholz, S H Goey, C J Punt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 20, 2024
Immune checkpoint inhibitor-induced pancreatic enzyme elevation in melanoma patients: Incidence, management and therapy-A multicentre analysis
M Brandlmaier, M Hoellwerth, T Silly, et al.
British Journal of Cancer
|
April 20, 2001
Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
A Hauschild, C Garbe, W Stolz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 29, 2015
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study
M Kunz, M Urosevic-Maiwald, S M Goldinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
K Spieth, R Kaufmann, R Dummer, et al.
Frontiers in Oncology
|
December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
H S Gabryś, L Basler, S Burgermeister, et al.
Nature Medicine
|
October 5, 2021
Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial
R Dummer, D E Gyorki, J Hyngstrom, et al.
The British Journal of Dermatology
|
September 2, 2018
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial
E Stockfleth, G F L Hofbauer, U Reinhold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2011
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
R von Moos, B Seifert, M Simcock, et al.
Page
of 33